In an effort to support global initiatives to contain the spread of the new coronavirus (COVID-19), the Academy is moving to an online platform or postponing all meetings and events intended to be held in person through April 30, 2020. Please check here for more information, including Academy programs on COVID-19, and links to the latest advisories from public health officials.

We are experiencing intermittent technical difficulties. At this time, you may not be able to log in, register for an event, or make a donation via the website. We appreciate your patience, and apologize for any inconvenience this may cause.

This site uses cookies.
Learn more.


This website uses cookies. Some of the cookies we use are essential for parts of the website to operate while others offer you a better browsing experience. You give us your permission to use cookies, by continuing to use our website after you have received the cookie notification. To find out more about cookies on this website and how to change your cookie settings, see our Privacy policy and Terms of Use.


Animal Models

Edited by Edited by Annals of the New York Academy of Sciences editorial staff
Animal Models

Published: December 2011

Volume 1245

Learn More

This volume stems from the conference “Animal Models and Their Value in Predicting Drug Efficacy and Toxicity,” which was jointly presented by the Global Medical Excellence Cluster and the New York Academy of Sciences, in collaboration with the Centre for Integrative Mammalian Physiology and Pharmacology at Imperial College London and King’s College London. The conference was generously supported by Bronze Sponsors, GlaxoSmithKline, Pfizer, sanofi-aventis, the Global Medical Excellence Cluster, and the Wellcome Trust; and also by Academy Friend Sponsors, Bristol-Myers Squibb, the British Pharmacological Society, Charles River, Imperial College London, King's College London, the National Swine Research and Resource Center, Sigma Advanced Genetic Engineering (SAGE Labs), Taconic, the Jackson Laboratory, and the Physiological Society. Additional funding was made possible, in part, by the Office of the Director of the National Institute of Environmental Health Sciences (NIEHS), the National Center for Research Resources (NCRR), the National Institute of General Medical Sciences (NIGMS), and the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).